Source: Benzinga

Zosano Pharma: Why Zosano Pharma's Stock Is Trading Lower Today

Zosano Pharma (NASDAQ: ZSAN) shares are trading lower on Wednesday after the company announced it received a complete response letter from the FDA for its Qtrypta. Zosano Pharma is a ...Full story available on Benzinga.com

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Annual Revenue
Employees
Steven Lo's photo - President & CEO of Zosano Pharma

President & CEO

Steven Lo

CEO Approval Rating

83/100

Zosano Pharma is a clinical-stage biopharmaceutical company that researches, develops and commercializes novel therapeutics to treat migraines. Read more